pillbase.ru

Evenity

Active substance: Romosozumab

romosozumab

Centralised EU authorisationActive

Marketing holder: UCB Pharma S.A.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 2
  • ИВЕНИТИ®
    раствор для подкожного введения, 90 мг/мл, 1.17 мл (original in Russian, GRLS)
    ЛП-№(009365)-(РГ-RU)
    Амджен Европа Б.В.
  • Ивенити®
    раствор для подкожного введения, 90 мг/мл, 1.17 мл (original in Russian, GRLS)
    ЛП-008616
    Амджен Европа Б.В.
US 3
  • Evenity
    INJECTION, SOLUTION · ROMOSOZUMAB 105 mg/1.17mL
    55513-509
    Amgen, Inc
  • Evenity
    INJECTION, SOLUTION · ROMOSOZUMAB 105 mg/1.17mL
    55513-998
    Amgen, Inc
  • Evenity
    INJECTION, SOLUTION · ROMOSOZUMAB 105 mg/1.17mL
    55513-880
    Amgen, Inc
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c3-a4a2-7d7c-ad73-9bb3f6fc3ce3,01a120c6-19ea-72db-829d-be33280daec7;count=2 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-e0b5-751a-ab0a-5e49e6ec2030,01a12093-c4f8-7f7e-9b1c-92226bd34f40,01a1209b-3cb2-7121-8efb-9d7b151beaca;count=3 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/004465
Registration status
Active
ATC code
M05BX
Sources
  • product · EMA · EMEA/H/C/004465 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/004465 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/004465 · Verified 2026-10-09